P607 Higher adalimumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 25, 2019
has subject area
- 1103 Clinical Sciences (FoR)
- Gastroenterology & Hepatology (Science Metrix)
published in
- Journal of Crohn's and Colitis Journal